surmount-1 tirzepatide trial weight loss non-diabetic for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide Yields Top Weight Loss

The first category includes pain management medications: gabapentin, pregabalin, duloxetine, tricyclic antidepressants, and topical lidocaine or capsaicin

Start Mounjaro 2.5 mg weekly for 4 weeks, then 5 mg

Kaplan, MD, PhD

At Set Point Medical Weight Loss Clinic, we place a strong emphasis on lifestyle modifications alongside medication

For instance, the OASIS 1 trial reported an average weight loss of 14.9% for those taking oral semaglutide

Starting Dose and Titration Schedule Retatrutide phase 2 used a structured titration: Weeks 1 to 4: 2 mg subcutaneous once weekly Weeks 5 to 8: 4 mg once weekly Weeks 9 to 12: 8 mg once weekly Week 13 onward: 12 mg once weekly (maximum dose) Gastrointestinal adverse events drove dose reductions in 15.7% of participants receiving 12 mg in the phase 2 trial